Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 16 Oct 2026 for Champions Oncology, INC., €100k. Read the official filing
Filing timeline
BuySaleJoel Ackerman
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Joel Ackerman: trading record in brief
Joel Ackerman (finance chief) discloses dealings in 2 companies, chiefly Davita Inc. and Champions Oncology, Inc. Between 15 May 2021 and 15 October 2026, the trades on record add up to 33 filings.
No open-market purchase appears, only 2 sales worth €13.1M. The rest of the record consists of 19 share grants and 11 option exercises.
The latest filing, published on 16 October 2026, reports an option exercise of €100k in Champions Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joel Ackerman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
69,794 shares@ US$1.60Common StockSEC:0001628280-26-066091:0
5,706 shares0Common StockSEC:0000927066-26-000038:0
3,362 shares@ US$150.720.0035% mcap0.8% of flowCommon StockSEC:0000927066-26-000038:1
33,693 shares@ US$150.720.035% mcap7.8% of flowCommon StockSEC:0000927066-26-000038:2
5,765 shares@ US$150.720.0060% mcap1.3% of flowCommon StockSEC:0000927066-26-000038:3
6,585 shares0Common StockSEC:0000927066-26-000017:0
44,065 shares@ US$108.930.032% mcap7.2% of flowCommon StockSEC:0000927066-26-000008:0
94,405 shares@ US$2.1027.4% of flowCommon StockSEC:0001628280-25-049954:0
3,093 shares@ US$143.450.7% of flowCommon StockSEC:0000927066-25-000056:1
3,331 shares@ US$143.450.8% of flowCommon StockSEC:0000927066-25-000056:2
5,995 shares0Common StockSEC:0000927066-25-000056:0
7,394 shares0Common StockSEC:0000927066-25-000018:0
88,470 shares@ US$2.1027.4% of flowCommon StockSEC:0001628280-24-044663:0
21,602 shares@ US$163.565.6% of flowCommon StockSEC:0000927066-24-000167:2
78,999 shares@ US$75.959.5% of flowCommon StockSEC:0000927066-24-000167:0
36,684 shares@ US$163.569.5% of flowCommon StockSEC:0000927066-24-000167:1
64,029 shares@ US$155.063915.7% of flowCommon StockSEC:0000927066-24-000157:0
14,349 shares0Common StockSEC:0000927066-24-000043:0
55,000 shares@ US$52.414.7% of flowCommon StockSEC:0000927066-24-000034:0
55,000 shares@ US$52.414.7% of flowCommon StockSEC:0000927066-24-000024:0
114,552 shares@ US$2.1036.4% of flowCommon StockSEC:0001628280-24-000639:0
7,625 shares@ US$96.861.2% of flowCommon StockSEC:0000927066-23-000145:0
56,306 shares@ US$66.296.0% of flowCommon StockSEC:0000927066-23-000107:0
2,790 shares0Common StockSEC:0000927066-23-000075:0
23,672 shares0Common StockSEC:0000927066-23-000067:0
25 of 33 declarations
